As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...